Findings

What do systematic reviews say?

4,815 questions · 6,211 findings · 638 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,052 · 16.9%GRADE not reported 441 · 7.1%Very low 1,700 · 27.4%Low 1,651 · 26.6%Moderate 1,070 · 17.2%High 297 · 4.8%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 188 participants
High

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 746 participants
Moderate

Intervention not reported

Laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 1296 participants
Moderate

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 487 participants
Moderate

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 185 participants
Low

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 170 participants
Very low

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 139 participants
Low

Intervention not reported

Laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 559 participants
High

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 261 participants
Low

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 640 participants
Moderate

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 154 participants
Moderate

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 261 participants
Moderate

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Moderate

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Moderate

Intervention not reported

Laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 563 participants
Moderate

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 2644 participants
Very low

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 305 participants
Low

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 368 participants
Low

Intervention not reported

Conbercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 125 participants
Very low

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 154 participants
Low